U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07655583) titled 'OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy' on June 15.

Brief Summary: To remove a brain tumor, patients usually receive radiation to lower the chance that the cancer will come back in the spot where the tumor was removed.

Study Start Date: May 27

Study Type: OBSERVATIONAL

Condition: Brain Metastasis Stereotactic Radiosurgery Resection Systemic Therapy

Intervention: OTHER: Systemic therapy

Systemic therapy regimen consisting of one of the following: dual-agent immune checkpoint inhibitors (e.g. ipilimumab and nivolumab) for melanoma, os...